Advertisement
AME vs EMR
Which Stock Would AI Choose? AMETEK (AME) vs. Emerson Electric (EMR) Stock Comparison
Key Takeaways
- AME and EMR are both premier industrial technology companies with significant exposure to automation, aerospace, and energy end markets, making them frequent peers in investor portfolios.
- AMETEK has demonstrated consistent margin expansion and disciplined capital deployment through its proven acquisition strategy, while Emerson has undergone a major portfolio transformation toward pure-play automation.
- Both stocks have benefited from secular tailwinds including reshoring, energy transition, and industrial digitization, though their paths to capturing these trends differ materially.
- Recent market activity suggests Emerson's more aggressive restructuring narrative has attracted momentum-oriented investors, while AMETEK's steady compounding model appeals to long-term allocators.
- Valuation, dividend profiles, and sector weightings create meaningful differentiation that may suit different investor objectives in the current market environment.
Introduction
Investors seeking exposure to industrial innovation frequently encounter two standout names: AME (AMETEK, Inc.) and EMR (Emerson Electric Co.). Both companies have evolved far beyond their manufacturing roots to become technology-driven leaders serving critical sectors including aerospace, energy, and automation. This stock comparison examines how these two industrial heavyweights stack up across key dimensions — business models, recent performance, growth drivers, and market positioning — offering a timely reference for traders and investors evaluating relative opportunities in the industrial technology space.
AME Overview and Recent Performance
AME, or AMETEK, Inc., operates as a global manufacturer of electronic instruments and electromechanical devices, organized into two segments: Electronic Instruments Group (EIG) and Electromechanical Group (EMG). The company serves a diverse range of end markets including aerospace and defense, medical, industrial automation, and energy. AMETEK's growth model is anchored in the "AMETEK Growth Model," which combines operational excellence, new product development, and a disciplined acquisition strategy (typically bolt-on deals that are immediately accretive) that has delivered decades of consistent compounding.
In recent weeks, AMETEK shares have traded within a relatively stable range, reflecting the company's reputation for predictable earnings growth. The stock has generally held up well amid broader industrial sector fluctuations, supported by strong aerospace demand and steady orders across its niche instrumentation businesses. Analysts have noted AMETEK's resilient margins and strong free cash flow generation as key attributes that have sustained investor confidence. The company's acquisition pipeline remains active, and recent quarterly communications have highlighted continued strength in process instrumentation and aerospace aftermarket demand. While not the most volatile name in the sector, AMETEK's steady performance trajectory continues to attract institutional interest.
EMR Overview and Recent Performance
EMR, or Emerson Electric Co., has undergone a significant transformation in recent years, sharpening its focus to become a global leader in industrial automation and process control. Following the divestiture of its climate technologies business and the strategic merger of its software unit with AspenTech, Emerson now concentrates on intelligent devices, software, and services that help customers optimize operations across industries including energy, chemical, pharmaceutical, and discrete manufacturing. This portfolio reshaping has repositioned the company squarely around high-growth automation markets.
Emerson's stock has experienced notable momentum in recent market activity, buoyed by strong order growth in process automation and favorable secular trends around energy security, sustainability, and digital transformation. The company's increased exposure to LNG (liquefied natural gas) infrastructure, clean energy projects, and industrial IoT (Internet of Things) has resonated with investors looking for infrastructure-linked growth. Recent quarterly results have underscored robust demand across most end markets, with particular strength in North American process automation. Emerson's pivot toward a higher-margin, software-enabled business model has been well-received, though some analysts have flagged integration risks related to recent acquisitions and the AspenTech majority ownership structure.
Trending AI Robots
Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to navigate dynamic market conditions. With hundreds of AI trading bots available on the platform — each trading across thousands of different tickers with distinct strategies, timeframes, and risk parameters — only those demonstrating the strongest real-time alignment with current market conditions earn placement in this featured section. Users can explore bots with varied approaches ranging from swing trading to trend following, with performance statistics including win rates, trade frequency, and return profiles. Each bot operates autonomously, applying its proprietary algorithm to its designated set of tickers. To discover which AI trading strategies are currently outperforming, visit the Trending AI Robots page and explore the bots best suited to today's market environment.
Head-to-Head Comparison
While both AME and EMR compete in industrial technology, their business models diverge in meaningful ways. AMETEK operates a highly decentralized portfolio of niche businesses, typically holding dominant positions in specialized instrumentation and precision components markets. Emerson, by contrast, has concentrated its portfolio on large-scale automation platforms, control systems, and industrial software — a more integrated value proposition targeting enterprise-level customers.
From a sector exposure perspective, AMETEK carries greater weight in aerospace and defense, which has been a tailwind amid elevated commercial aerospace demand. Emerson's heavier tilt toward energy and process industries means it is more leveraged to capital expenditure (CapEx) cycles in oil and gas, LNG, and chemical processing. This difference creates diverging sensitivity to commodity prices and energy investment trends.
On valuation, Emerson's transformation narrative has historically commanded a premium multiple at times, though the gap with AMETEK fluctuates based on quarterly execution and market sentiment. AMETEK's consistent compounding record often justifies its valuation, but Emerson's higher-growth software and automation exposure may attract those seeking greater upside potential. Dividend investors will note that both companies have strong dividend growth track records, though yields and payout ratios differ based on capital allocation priorities — AMETEK typically reinvests more heavily in M&A (mergers and acquisitions), while Emerson balances shareholder returns with strategic portfolio moves.
Risk factors also differ: AMETEK faces integration risk from its rapid-fire acquisition pace, while Emerson's transformation execution risk and AspenTech-related complexity remain key considerations. In recent market activity, Emerson's stock has shown higher beta (a measure of volatility relative to the broader market), while AMETEK's more defensive characteristics have provided relative stability.
Tickeron AI Verdict
Based on observable trend consistency, relative momentum, and current market positioning, Tickeron's AI analysis would likely find both stocks compelling but for different reasons. Emerson's stronger near-term momentum, driven by its automation-focused transformation and favorable energy infrastructure tailwinds, could give it a tactical edge in trend-following frameworks. However, AMETEK's steadier price action, more predictable earnings trajectory, and diversified niche exposure may score higher on stability and consistency metrics. The probabilistic assessment suggests that in the current environment, Emerson might attract AI models favoring momentum and thematic exposure, while AMETEK remains a high-confidence candidate for models prioritizing lower volatility and compounding reliability. The relative preference depends on the specific algorithmic framework applied, with both stocks presenting distinct investment cases that sophisticated AI tools can help evaluate.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AME is a StrongBuy and EMR is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AME’s FA Score shows that 2 FA rating(s) are green whileEMR’s FA Score has 2 green FA rating(s).
- AME’s FA Score: 2 green, 3 red.
- EMR’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AME’s TA Score shows that 4 TA indicator(s) are bullish while EMR’s TA Score has 5 bullish TA indicator(s).
- AME’s TA Score: 4 bullish, 3 bearish.
- EMR’s TA Score: 5 bullish, 5 bearish.
Price Growth
AME (@Industrial Machinery) experienced а -0.47% price change this week, while EMR (@Industrial Machinery) price change was +1.27% for the same time period.
The average weekly price growth across all stocks in the @Industrial Machinery industry was -1.16%. For the same industry, the average monthly price growth was -10.62%, and the average quarterly price growth was -4.31%.
Reported Earning Dates
AME is expected to report earnings on Aug 04, 2026.
EMR is expected to report earnings on Aug 04, 2026.
Industries' Descriptions
@Industrial Machinery (-1.16% weekly)The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.
| AME | EMR | AME / EMR | |
| Capitalization | 55B | 83.9B | 66% |
| EBITDA | 2.36B | 5.05B | 47% |
| Gain YTD | 17.262 | 13.776 | 125% |
| P/E Ratio | 36.26 | 34.68 | 105% |
| Revenue | 7.6B | 18.3B | 42% |
| Total Cash | N/A | 1.79B | - |
| Total Debt | 2.18B | 14.1B | 15% |
AME | EMR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 72 | 41 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 74 Overvalued | 32 Undervalued | |
PROFIT vs RISK RATING 1..100 | 16 | 31 | |
SMR RATING 1..100 | 59 | 64 | |
PRICE GROWTH RATING 1..100 | 48 | 51 | |
P/E GROWTH RATING 1..100 | 27 | 70 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EMR's Valuation (32) in the Electrical Products industry is somewhat better than the same rating for AME (74) in the Miscellaneous Manufacturing industry. This means that EMR’s stock grew somewhat faster than AME’s over the last 12 months.
AME's Profit vs Risk Rating (16) in the Miscellaneous Manufacturing industry is in the same range as EMR (31) in the Electrical Products industry. This means that AME’s stock grew similarly to EMR’s over the last 12 months.
AME's SMR Rating (59) in the Miscellaneous Manufacturing industry is in the same range as EMR (64) in the Electrical Products industry. This means that AME’s stock grew similarly to EMR’s over the last 12 months.
AME's Price Growth Rating (48) in the Miscellaneous Manufacturing industry is in the same range as EMR (51) in the Electrical Products industry. This means that AME’s stock grew similarly to EMR’s over the last 12 months.
AME's P/E Growth Rating (27) in the Miscellaneous Manufacturing industry is somewhat better than the same rating for EMR (70) in the Electrical Products industry. This means that AME’s stock grew somewhat faster than EMR’s over the last 12 months.
| AME | EMR | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 40% |
| Stochastic ODDS (%) | 2 days ago 37% | 2 days ago 56% |
| Momentum ODDS (%) | 2 days ago 53% | 2 days ago 62% |
| MACD ODDS (%) | 2 days ago 57% | 2 days ago 69% |
| TrendWeek ODDS (%) | 2 days ago 46% | 2 days ago 58% |
| TrendMonth ODDS (%) | 2 days ago 48% | 2 days ago 54% |
| Advances ODDS (%) | 5 days ago 49% | 4 days ago 60% |
| Declines ODDS (%) | 3 days ago 46% | 24 days ago 57% |
| BollingerBands ODDS (%) | 2 days ago 37% | 2 days ago 57% |
| Aroon ODDS (%) | 2 days ago 48% | 2 days ago 58% |
Advertisement